Building on 'flu shot' success to tackle COVID-19

by CAS, a division of the American Chemical Society

4 years ago
flu, vaccine, COVID-19, respiratory virus

Pharmaceutical companies and public health officials are leveraging experience with the well-known influenza vaccine to support successful development, production and administration of a vaccine(s) ag...

Seeking COVID-19 Therapeutic Candidates with a Computational Approach

by CAS, a division of the American Chemical Society

4 years ago
ACS Omega, COVID-19, machine learning, vaccine, antiviral treatments

Since the World Health Organization declared COVID-19 a pandemic, researchers have learned a tremendous amount about SARS-CoV-2, the new coronavirus that causes this disease. However, despite extensiv...

Building efficiency into the vaccine manufacturing process

by Telstar

4 years ago
plant process, aseptic process solutions, cGMP, pharmaceutical production, vaccine

Telstar’s end-to-end engineering & GMP services are highly specialized in offering an integrated solution covering all the phases of an injectable vaccine production plant.

CiQUS's contribution to the search for a COVID-19 vaccine

by Centro Singular de Investigación en Química Biológica y Materiales Moleculares

4 years ago
El País, vaccine, COVID-19, biomedical challenges

Spain’s main newspaper, El País, in the article “The dream of a Spanish Covid vaccine” of 21 June, reports on two of the research projects under way at CiQUS.

Optimizing the vaccine manufacturing process

by Telstar

4 years ago
pharmaceutical, vaccine, process, production

Telstar’s cutting-edge technologies and integrated systems have proven to offer high output in all the phases of the injectable vaccine production. Involved in each stage of the complete manufacturi...

Pall Corporation Participates in a Consortium to Rapidly Develop a COVID-19 Vaccine

by Pall Biotech

4 years ago
immune, vaccine, covid-19

The consortium led by The University of Oxford is fast-tracking clinical trials beginning in April 2020

Eurofins Ingenasa participates in the VACDIVA Project, which aims to develop an effective vaccine against African Swine Fever (ASFV)

by Ingenasa

4 years ago
African Swine Fever, vaccine, Eurofins Ingenasa, VACDIVA Project

The VACDIVA project has been financed with 10 million euros by the European Union (EU) in the call “H2020-SFS-2019-1, topic: A vaccine against African Swine Fever”. The research works involve two ...

CIC bioGUNE researchers unravel the three-dimensional structure of the African swine fever virus

by CIC bioGUNE

5 years ago
vaccine, virus assembly, electron microscopy, african swine fever virus

This breakthrough is the prerequisite not only for understanding the virus assembly but also for controlling and ultimately eliminating it. The African swine fever virus infects both domestic and w...

IDIVAL patents a multivalent vaccine against listeriosis, tuberculosis and pneumonia

by Instituto de Investigación Marqués de Valdecilla

5 years ago
vaccine, listeriosis, tuberculosis, pneumonia, infections

After the last outbreak of listeriosis occurred in Spain, the bacterium Listeria monocytogenes, has established itself in Spain as one of the pathogens causing more virulent food infections.

For World Hepatitis Day, a Call to Expand and Simplify Early Testing

by ISGlobal - Instituto de Salud Global de Barcelona

5 years ago
hepatitis, testing, vaccine

The vast majority of people with chronic HBV or HCV infection remain undiagnosed or are diagnosed late

Protection by the Malaria Vaccine Is Not Only a Matter of Antibody Quantity but Also of Quality

by ISGlobal - Instituto de Salud Global de Barcelona

5 years ago
malaria, Vaccine, marker of protection, antibodies

A study shows for the first time that the higher the avidity of antibodies induced by the RTS,S vaccine, the greater the protection

Hepatitis B vaccination in preadolescents lowered the disease incidence rate in Catalonia

by Universitat de Barcelona

5 years ago
vaccine, hepatitis B, preadolescents, chronic infection

Introducing Hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 % according to a study in which the University of Barcelona (UB) took part.